Tate & Lyle’s low-calorie rare sugar product, allulose, is exempted by the FDA from the ‘Sugars’ and ‘Added Sugars’ line of the Nutrition Facts Panel in the U.S.
The FDA published draft guidance is a result of a nutrition-based review by the FDA in response to Tate & Lyle’s citizen’s petition. Allulose was required to be included in the ‘Sugars’ and ‘Added Sugars’ lines of the Nutrition Facts. It will continue to be included in the carbohydrate line of the Nutrition Fact Panel (with the negligible caloric impact on % daily value), and label simply as allulose in the ingredients list.
“Our regulatory, legal, nutrition and marketing teams have worked with the FDA to show the potential health benefit that allulose could have for U.S. consumers, if labeled in a clear and appropriate way,” said Abigail Storms, vice president of global strategic marketing at Tate & Lyle. “It’s very rewarding to receive this decision and unlock the great potential that allulose has to reduce calories in a significant way while delivering great taste and functionality.”
Allulose is one of many different rare sugars that exist in nature in very small quantities. Originally identified in wheat, it has since been found in certain fruits including figs and raisins.